Multicomponent Intervention to Reduce Sexual Risk and Substance Use
Status: | Completed |
---|---|
Conditions: | Infectious Disease, HIV / AIDS, Psychiatric |
Therapuetic Areas: | Immunology / Infectious Diseases, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/9/2018 |
Start Date: | June 2013 |
End Date: | November 2, 2017 |
The objective is to expand and refine an intervention for transgender women (TW) into a
7-session individual- and group-based intervention that is scalable for community settings to
reduce sexual risk and substance use and to increase stigma-coping and risk-buffering
behaviors among TW in NYC. The investigators will pilot test the intervention with 20 TW and
subsequently, conduct a randomized controlled trial with 240 TW to compare the intervention
to a wait list control condition.
7-session individual- and group-based intervention that is scalable for community settings to
reduce sexual risk and substance use and to increase stigma-coping and risk-buffering
behaviors among TW in NYC. The investigators will pilot test the intervention with 20 TW and
subsequently, conduct a randomized controlled trial with 240 TW to compare the intervention
to a wait list control condition.
Inclusion Criteria:
- 18 years of age or older
- Identify as a transgender woman (assigned male at birth and currently identify as
female)
- Report 3 or more acts of unprotected anal or vaginal sex in the past 90 days and at
least 1 in the past 30 days
- Report 5 or more days of illicit drug use in the past 90 days and at least 2 in the
past 30
- Provide contact information
- Reside in the NYC metropolitan area
- Able to complete a survey in English (Spanish-language assistance can be provided by
bilingual staff)
- Provide informed consent
Exclusion Criteria:
- Unstable, serious psychiatric symptoms
- Current suicidal/homicidal ideation
- Evidence of gross cognitive impairment
- Currently enrolled in a drug abuse treatment or enrolled in an HIV risk or drug use
intervention study
We found this trial at
1
site
New York, New York 10001
Principal Investigator: Jeffrey T Parsons, Ph.D.
Phone: 212-206-7919
Click here to add this to my saved trials